Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Gaza Flotilla Activists Allege Mistreatment by Israeli Forces Raising Geopolitical Tensions Microsoft in Talks to Supply Custom AI Chips to Anthropic Following 5 Billion Investment Analyst Mehul Kothari Highlights Yes Bank PNB Bandhan Bank as Stocks Under 200 Amid Market Caution Fed Interest Rate Hike Expected as Soon as December Futures Markets Signal After Inflation Data Hindalco Investors Eye MediumTerm Gains Amid Q4 Profit Halve but Valuation Concerns Linger Safehold Inc SAFE Q1 2026 Earnings EPS Miss Weighs on Shares Despite Stable Ground Lease Portfolio General Dynamics Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction VSTS Q1 2026 Earnings EPS Surges 89 Above Estimates Stock Gains Ark Restaurants Q4 2025 Earnings Net Loss Reported No Revenue Detail Disclosed IMRX Q1 2026 Earnings Narrower Loss Exceeds Expectations as Pipeline Progress Continues Columbus Circle Capital Corp II Warrants CMIIW Remain Flat at 034 as Investors Await Catalyst OraSure Technologies OSUR Surges 9 Key Levels to Watch After Strong Move Aditxt Inc ADTX Plunges 1957 Key Support Level Tested at 019 Title Lockheed Martin LMT Edges Lower in Consolidation Zone Key Support and Resistance Levels Under Watch Analyst Sees 38 Upside Potential for Pfizer Stock Citing Pipeline Progress UAE and Iraq Accelerate Pipeline Projects to Reduce Strait of Hormuz Dependence Three Space Companies Enter Public Markets A Framework for Evaluating Their Potential Meta Shares Decline Following Quarterly Results as Iran Internet Disruptions Impact User Growth ADUS Q1 2026 Earnings EPS Beats Estimates by 242 Stock Edges Higher FOA Q1 2026 Earnings Strong EPS Surprise Amidst Uncertain Revenue Outlook PAVmed Q1 2026 Earnings Massive EPS Miss as PreRevenue Company Reports No Sales HWBK Q1 2026 Earnings Strong EPS Performance Amid No Revenue Guidance DHIL Q1 2025 Earnings EPS of 323 Reported Amidst Market Uncertainty KURA Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates as Pipeline Development Intensifies